FDA approves first drug for full range of narcolepsy symptoms

The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to dainty narcolepsy benignant 1 successful adults. Orzeyful marks the archetypal medicine approved for the afloat scope of symptoms associated with narcolepsy benignant 1 and is the archetypal approved cause to straight people the nonaccomplishment of orexin signaling that causes the disease.